Cytokinetics Inc. buy Wells Fargo & Company
Start price
10.04.26
/
50%
€55.40
Target price
10.04.27
€81.26
Performance (%)
0.04%
Price
10.04.26
€55.42
Summary
This prediction is currently active. Since the start of the prediction for Cytokinetics Inc. the price has only changed by 0.04%. This prediction currently runs until 10.04.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Cytokinetics Inc. | 0.04% |
| iShares Core DAX® | 2.554% |
| iShares Nasdaq 100 | 2.742% |
| iShares Nikkei 225® | 6.584% |
| iShares S&P 500 | 1.930% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (CYTK) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $95.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat

